Peter Manza1, Dardo Tomasi2, Nora D Volkow3. 1. National Institute on Alcoholism and Alcohol Abuse, National Institutes of Health, Bethesda, Maryland. Electronic address: peter.manza@nih.gov. 2. National Institute on Alcoholism and Alcohol Abuse, National Institutes of Health, Bethesda, Maryland. 3. National Institute on Alcoholism and Alcohol Abuse, National Institutes of Health, Bethesda, Maryland; National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland.
Abstract
BACKGROUND: Cannabis abuse (CA) has been associated with psychopathology, including negative emotionality and higher risk of psychosis, particularly with early age of initiation. However, the mechanisms underlying this association are poorly understood. Because aberrant dopamine signaling is implicated in cannabis-associated psychopathology, we hypothesized that regular CA would be associated with altered resting-state functional connectivity in dopamine midbrain-striatal circuits. METHODS: We examined resting-state brain activity of subcortical regions in 441 young adults from the Human Connectome Project, including 30 subjects with CA meeting DSM-IV criteria for dependence and 30 control subjects matched on age, sex, education, body mass index, anxiety, depression, and alcohol and tobacco usage. RESULTS: Across all subjects, local functional connectivity density hubs in subcortical regions were most prominent in ventral striatum, hippocampus, amygdala, dorsal midbrain, and posterior-ventral brainstem. As hypothesized, subjects with CA showed markedly increased local functional connectivity density relative to control subjects, not only in ventral striatum (where nucleus accumbens is located) and midbrain (where substantia nigra and ventral tegmental nuclei are located) but also in brainstem and lateral thalamus. These effects were observed in the absence of significant differences in subcortical volumes and were most pronounced in individuals who began cannabis use earliest in life and who reported high levels of negative emotionality. CONCLUSIONS: Together, these findings suggest that chronic CA is associated with changes in resting-state brain function, particularly in dopaminergic nuclei implicated in psychosis but that are also critical for habit formation and reward processing. These results shed light on neurobiological differences that may be relevant to psychopathology associated with cannabis use. Published by Elsevier Inc.
BACKGROUND:Cannabis abuse (CA) has been associated with psychopathology, including negative emotionality and higher risk of psychosis, particularly with early age of initiation. However, the mechanisms underlying this association are poorly understood. Because aberrant dopamine signaling is implicated in cannabis-associated psychopathology, we hypothesized that regular CA would be associated with altered resting-state functional connectivity in dopamine midbrain-striatal circuits. METHODS: We examined resting-state brain activity of subcortical regions in 441 young adults from the Human Connectome Project, including 30 subjects with CA meeting DSM-IV criteria for dependence and 30 control subjects matched on age, sex, education, body mass index, anxiety, depression, and alcohol and tobacco usage. RESULTS: Across all subjects, local functional connectivity density hubs in subcortical regions were most prominent in ventral striatum, hippocampus, amygdala, dorsal midbrain, and posterior-ventral brainstem. As hypothesized, subjects with CA showed markedly increased local functional connectivity density relative to control subjects, not only in ventral striatum (where nucleus accumbens is located) and midbrain (where substantia nigra and ventral tegmental nuclei are located) but also in brainstem and lateral thalamus. These effects were observed in the absence of significant differences in subcortical volumes and were most pronounced in individuals who began cannabis use earliest in life and who reported high levels of negative emotionality. CONCLUSIONS: Together, these findings suggest that chronic CA is associated with changes in resting-state brain function, particularly in dopaminergic nuclei implicated in psychosis but that are also critical for habit formation and reward processing. These results shed light on neurobiological differences that may be relevant to psychopathology associated with cannabis use. Published by Elsevier Inc.
Authors: Jesus Pujol; Laura Blanco-Hinojo; Albert Batalla; Marina López-Solà; Ben J Harrison; Carles Soriano-Mas; Jose A Crippa; Ana B Fagundo; Joan Deus; Rafael de la Torre; Santiago Nogué; Magí Farré; Marta Torrens; Rocío Martín-Santos Journal: J Psychiatr Res Date: 2013-12-28 Impact factor: 4.791
Authors: Nicolas A Crossley; Andrea Mechelli; Jessica Scott; Francesco Carletti; Peter T Fox; Philip McGuire; Edward T Bullmore Journal: Brain Date: 2014-06-19 Impact factor: 13.501
Authors: Daniel J DeDora; Sanja Nedic; Pratha Katti; Shafique Arnab; Lawrence L Wald; Atsushi Takahashi; Koene R A Van Dijk; Helmut H Strey; Lilianne R Mujica-Parodi Journal: Front Neurosci Date: 2016-05-04 Impact factor: 4.677
Authors: Lisa Buchy; Tyrone D Cannon; Alan Anticevic; Kristina Lyngberg; Kristin S Cadenhead; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Daniel H Mathalon; Jean Addington Journal: BMC Psychiatry Date: 2015-11-09 Impact factor: 3.630
Authors: Sheri L Towe; Christina S Meade; Christine C Cloak; Ryan P Bell; Julian Baptiste; Linda Chang Journal: J Neuroimmune Pharmacol Date: 2020-05-22 Impact factor: 4.147
Authors: Katherine L McPherson; Dardo G Tomasi; Gene-Jack Wang; Peter Manza; Nora D Volkow Journal: Front Psychiatry Date: 2021-05-13 Impact factor: 4.157
Authors: Shana A Hall; Zahra Lalee; Ryan P Bell; Sheri L Towe; Christina S Meade Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2020-07-18 Impact factor: 5.067
Authors: Andrew J Kesner; Yolanda Mateo; Karina P Abrahao; Stephanie Ramos-Maciel; Matthew J Pava; Alexa L Gracias; Riley T Paulsen; Hartley B Carlson; David M Lovinger Journal: Neuropsychopharmacology Date: 2022-04-27 Impact factor: 8.294
Authors: Liangsuo Ma; John M Hettema; Janna Cousijn; James M Bjork; Joel L Steinberg; Lori Keyser-Marcus; Kyle Woisard; QiQi Lu; Roxann Roberson-Nay; Antonio Abbate; F Gerard Moeller Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2020-10-07